ES474697A1 - Un procedimiento para preparar interferon de leucocito por- cino exogeno - Google Patents

Un procedimiento para preparar interferon de leucocito por- cino exogeno

Info

Publication number
ES474697A1
ES474697A1 ES474697A ES474697A ES474697A1 ES 474697 A1 ES474697 A1 ES 474697A1 ES 474697 A ES474697 A ES 474697A ES 474697 A ES474697 A ES 474697A ES 474697 A1 ES474697 A1 ES 474697A1
Authority
ES
Spain
Prior art keywords
interferon
human
porcine
bands
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474697A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ESS FOOD DANISH BACON FACT
Original Assignee
ESS FOOD DANISH BACON FACT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ESS FOOD DANISH BACON FACT filed Critical ESS FOOD DANISH BACON FACT
Publication of ES474697A1 publication Critical patent/ES474697A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES474697A 1977-11-01 1978-10-31 Un procedimiento para preparar interferon de leucocito por- cino exogeno Expired ES474697A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK485977A DK485977A (da) 1977-11-01 1977-11-01 Fremgangsmaade til udvinding af et biologisk aktivt materiale fra svineblodfraktioner

Publications (1)

Publication Number Publication Date
ES474697A1 true ES474697A1 (es) 1979-11-01

Family

ID=8137298

Family Applications (1)

Application Number Title Priority Date Filing Date
ES474697A Expired ES474697A1 (es) 1977-11-01 1978-10-31 Un procedimiento para preparar interferon de leucocito por- cino exogeno

Country Status (7)

Country Link
US (1) US4273703A (da)
EP (1) EP0002318A1 (da)
JP (1) JPS5625196A (da)
DK (1) DK485977A (da)
ES (1) ES474697A1 (da)
FI (1) FI783310A (da)
IT (1) IT7869515A0 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
US6410697B1 (en) * 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
WO1982000588A1 (en) * 1980-08-22 1982-03-04 Illinois Univ Delivery of biologically active components of heterologous species interferon isolates
US4462985A (en) * 1980-08-22 1984-07-31 University Of Illinois Foundation Delivery of biologically active components of heterologous species interferon isolates
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
US4605394A (en) * 1982-12-03 1986-08-12 Simon V. Skurkovich Methods for the treatment of pathological conditions by removing interferon from the organism
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
US8029454B2 (en) 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
US8114276B2 (en) 2007-10-24 2012-02-14 Baxter International Inc. Personal hemodialysis system

Also Published As

Publication number Publication date
FI783310A (fi) 1979-05-02
DK485977A (da) 1979-05-02
EP0002318A1 (en) 1979-06-13
JPS5625196A (en) 1981-03-10
IT7869515A0 (it) 1978-11-02
US4273703A (en) 1981-06-16

Similar Documents

Publication Publication Date Title
ES474697A1 (es) Un procedimiento para preparar interferon de leucocito por- cino exogeno
JPS5598118A (en) Preparation of type-2 interferon and drug containing the same
JPS568689A (en) Low cholesterine blood desease fermentation product and production thereof
NZ192991A (en) Preparation of purified protein hydrolysate
ES2156852T3 (es) Citoquina mamifera, il-11.
PT88626A (pt) Process for the preparation of a polypeptide growth factormilk
YU36854B (en) Process for obtaining proteinic concentrates suitable as nutrients by means of elimination of phenol and oligsaccharides from vegetable tissue
IE41064B1 (en) Peptides having lh-rh/fsh-rh activity and process for preparing them
AU586822B2 (en) Novel human interferon-Y polypeptide derivative
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
DE3061854D1 (en) Process for the preparation of interferon and culture medium composition used in it
HU895788D0 (en) Process for producing peptides and medical products containing them
NO800724L (no) Fremgangsmaate til fremstilling peptider med ubiquitinlignende aktivitet
IE40267L (en) Alkanolamine derivatives
EP0094317A3 (en) Production of interleukin and its analogous immune regulating factors
DE3164719D1 (en) Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation
IE781315L (en) Virus cultivation
NL169337C (nl) Werkwijze voor de bereiding van vormmassa's van macromoleculaire thermoplastische polycarbonaten, alsmede daarvan vervaardigd gevormd voortbrengsel.
EP0081478A3 (en) Novel halophenyl-pyridyl-allylamine derivatives, processes and intermediates as well as pharmaceutical preparations thereof
IL49305A (en) Preparation of protein enriched products from grain gluten
IE40191B1 (en) Steroid-binding globulin and process for the preparation thereof
NL7507376A (nl) Werkwijze voor de bereiding van bacteriele prepa- raten met anti-tumor, antivirale en adjuvans-acti- viteiten.
IE780205L (en) Insulin-secretion promoting protein.
AU501625B2 (en) Harvester crop table
EG12122A (en) Process for the preparation of new triazin-2,4-diones and their use as pesticides